Eulav Asset Management Exact Sciences Corp Transaction History

Eulav Asset Management

  • $4.25 Billion
  • Q2 2025

A detailed history of Eulav Asset Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Eulav Asset Management holds 283,000 shares of EXAS stock, worth $17.9 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
283,000
Previous 335,000 15.52%
Holding current value
$17.9 Million
Previous $14.5 Million 3.7%
% of portfolio
0.35%
Previous 0.36%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$40.31 - $58.08 $2.1 Million - $3.02 Million
-52,000 Reduced 15.52%
283,000 $15 Million
Q1 2025

Apr 29, 2025
BUY
$43.04 - $58.51 $2.15 Million - $2.93 Million
50,000 Added 17.54%
335,000 $14.5 Million
Q4 2024

Jan 28, 2025
SELL
$49.33 - $71.97 $986,600 - $1.44 Million
-20,000 Reduced 6.56%
285,000 $16 Million
Q3 2024

Nov 08, 2024
BUY
$42.43 - $70.83 $848,600 - $1.42 Million
20,000 Added 7.02%
305,000 $20.8 Million
Q2 2024

Aug 13, 2024
SELL
$41.33 - $74.26 $1.36 Million - $2.45 Million
-33,000 Reduced 10.38%
285,000 $12 Million
Q1 2024

May 30, 2024
BUY
$56.27 - $73.77 $3.43 Million - $4.5 Million
61,000 Added 23.74%
318,000 $22 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $1.06 Million - $1.36 Million
18,000 Added 7.53%
257,000 $19 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $923,160 - $1.39 Million
14,000 Added 6.22%
239,000 $16.3 Million
Q2 2023

Aug 09, 2023
SELL
$62.68 - $95.05 $313,400 - $475,250
-5,000 Reduced 2.17%
225,000 $21.1 Million
Q1 2023

Apr 27, 2023
SELL
$47.19 - $70.77 $1.18 Million - $1.77 Million
-25,000 Reduced 9.8%
230,000 $15.6 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $607,000 - $1.06 Million
-20,000 Reduced 7.27%
255,000 $12.6 Million
Q3 2022

Nov 03, 2022
SELL
$31.97 - $49.37 $319,700 - $493,700
-10,000 Reduced 3.51%
275,000 $8.94 Million
Q2 2022

Jul 22, 2022
SELL
$35.61 - $76.23 $676,590 - $1.45 Million
-19,000 Reduced 6.25%
285,000 $11.2 Million
Q1 2022

May 10, 2022
SELL
$57.56 - $82.54 $4.37 Million - $6.27 Million
-76,000 Reduced 20.0%
304,000 $21.3 Million
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $3.99 Million - $5.54 Million
55,000 Added 16.92%
380,000 $29.6 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $10.8 Million - $14.9 Million
120,000 Added 58.54%
325,000 $31 Million
Q2 2021

Aug 06, 2021
BUY
$93.66 - $139.27 $655,620 - $974,890
7,000 Added 3.54%
205,000 $25.5 Million
Q1 2021

Apr 30, 2021
SELL
$116.57 - $155.01 $2.33 Million - $3.1 Million
-20,000 Reduced 9.17%
198,000 $26.1 Million
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $2.49 Million - $3.55 Million
-25,000 Reduced 10.29%
218,000 $28.9 Million
Q3 2020

Nov 05, 2020
BUY
$72.92 - $102.01 $3.57 Million - $5 Million
49,000 Added 25.26%
243,000 $24.8 Million
Q2 2020

Aug 11, 2020
SELL
$55.75 - $92.75 $2.37 Million - $3.94 Million
-42,501 Reduced 17.97%
194,000 $16.9 Million
Q1 2020

Apr 27, 2020
BUY
$37.9 - $104.44 $2.08 Million - $5.74 Million
55,000 Added 30.3%
236,501 $13.7 Million
Q4 2019

Feb 13, 2020
BUY
$77.66 - $99.74 $2.17 Million - $2.79 Million
28,000 Added 18.24%
181,501 $16.8 Million
Q3 2019

Nov 12, 2019
SELL
$90.37 - $122.49 $2.85 Million - $3.86 Million
-31,499 Reduced 17.03%
153,501 $13.9 Million
Q2 2019

Aug 05, 2019
SELL
$89.51 - $118.04 $1.07 Million - $1.42 Million
-12,000 Reduced 6.09%
185,000 $21.8 Million
Q1 2019

May 13, 2019
SELL
$61.98 - $96.5 $1.36 Million - $2.12 Million
-22,000 Reduced 10.05%
197,000 $17.8 Million
Q4 2018

Feb 14, 2019
BUY
$56.04 - $82.66 $1.06 Million - $1.57 Million
19,000 Added 9.5%
219,000 $13.8 Million
Q3 2018

Oct 26, 2018
SELL
$48.29 - $80.6 $1.45 Million - $2.42 Million
-30,000 Reduced 13.04%
200,000 $15.8 Million
Q2 2018

Aug 14, 2018
BUY
$37.84 - $69.96 $908,160 - $1.68 Million
24,000 Added 11.65%
230,000 $13.8 Million
Q1 2018

May 09, 2018
BUY
$39.82 - $57.53 $1.23 Million - $1.78 Million
31,000 Added 17.71%
206,000 $8.31 Million
Q4 2017

Feb 14, 2018
SELL
$46.49 - $60.51 $1.86 Million - $2.42 Million
-40,000 Reduced 18.6%
175,000 $9.19 Million
Q3 2017

Nov 14, 2017
SELL
$37.05 - $47.12 $74,100 - $94,240
-2,000 Reduced 0.92%
215,000 $10.1 Million
Q2 2017

Aug 14, 2017
BUY
N/A
217,000
217,000 $7.68 Million

Others Institutions Holding EXAS

# of Institutions
650
Shares Held
156M
Call Options Held
1.43M
Put Options Held
2.3M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Eulav Asset Management Portfolio

Follow Eulav Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email